down arrow

Tivic Health Systems, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US8887052095
USD
2.04
0.26 (14.61%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

1.852.23

52 Week

1.4715.64
Valuation
Technical
Day's Volume

CASH

206.38 k

Shareholding (Mar 2025)

FII

0.00%

Held by 1 FIIs

DII

98.68%

Held by 1 DIIs

Promoter

0.00%

How big is Tivic Health Systems, Inc.?

22-Jun-2025

As of Jun 18, Tivic Health Systems, Inc. has a market capitalization of 3.67 million, with net sales of 0.52 million and a net profit of -5.68 million over the latest four quarters. Shareholder's funds are at 2.54 million and total assets at 2.81 million as of Dec 24.

As of Jun 18, Tivic Health Systems, Inc. has a market capitalization of 3.67 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of net sales for the latest four quarters is 0.52 million, while the sum of net profit for the same period is -5.68 million.<BR><BR>As of Dec 24, the reporting period shows shareholder's funds at 2.54 million and total assets at 2.81 million.

Read More

What does Tivic Health Systems, Inc. do?

22-Jun-2025

Tivic Health Systems, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $0 million and a net loss of $2 million as of March 2025, with a market cap of $3.67 million. Key metrics include a negative P/E ratio, a 0.00% dividend yield, and a return on equity of -186.96%.

Overview: <BR>Tivic Health Systems, Inc. operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 0 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -2 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 3.67 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.22 <BR>Return on Equity: -186.96% <BR>Price to Book: 1.21<BR><BR>Contact Details: <BR>Registrar Address: Not available.

Read More

Is Tivic Health Systems, Inc. overvalued or undervalued?

25-Jun-2025

As of November 14, 2024, Tivic Health Systems, Inc. is considered overvalued with deteriorating investment appeal, reflected in its negative financial metrics and poor performance compared to peers.

As of 14 November 2024, Tivic Health Systems, Inc. has seen its valuation grade change from risky to does not qualify, indicating a deterioration in its investment appeal. The company is currently assessed as overvalued given its financial metrics. Key ratios include a Price to Book Value of 1.10, an EV to EBIT of -0.47, and an EV to EBITDA of -0.50, all suggesting significant operational challenges.<BR><BR>In comparison to its peers, Tivic Health's valuation metrics are concerning. For instance, Nexalin Technology, Inc. has an EV to EBITDA of -2.0124, while Cardio Diagnostics Holdings, Inc. shows an EV to EBITDA of 0.5065, highlighting that Tivic Health is underperforming relative to some competitors. The company's negative ROCE of -240.22% and ROE of -186.96% further reinforce the notion that it is overvalued in the current market context.

Read More

Is Tivic Health Systems, Inc. technically bullish or bearish?

20-Sep-2025

As of September 2, 2025, Tivic Health Systems, Inc. is in a bearish trend with weak strength indicators, underperforming the S&P 500 significantly with year-to-date and one-year returns of -46.9% and -33.16%, respectively.

As of 2 September 2025, the technical trend for Tivic Health Systems, Inc. has changed from mildly bearish to bearish. The current stance is bearish with weak strength indicated by the daily moving averages and KST both showing bearish signals. The weekly MACD is mildly bullish, but this is offset by the bearish signals from Bollinger Bands and the monthly KST. The Dow Theory shows a mixed signal with weekly mildly bullish but monthly mildly bearish. <BR><BR>In terms of performance, Tivic Health has underperformed the S&P 500 across multiple periods, with a year-to-date return of -46.9% compared to the S&P 500's 12.22%, and a one-year return of -33.16% versus 17.14%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 5 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.32

stock-summary
Return on Equity

-171.98%

stock-summary
Price to Book

1.23

Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Jun 2025)
Net Profit:
-2 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-33.11%
0%
-33.11%
6 Months
-50.12%
0%
-50.12%
1 Year
-55.52%
0%
-55.52%
2 Years
-94.06%
0%
-94.06%
3 Years
70.0%
0%
70.0%
4 Years
-99.97%
0%
-99.97%
5 Years
0%
0%
0.0%

Tivic Health Systems, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is Tivic Health Systems, Inc. technically bullish or bearish?

As of 2 September 2025, the technical trend for Tivic Health Systems, Inc. has changed from mildly bearish to bearish. The current stance is bearish with weak strength indicated by the daily moving averages and KST both showing bearish signals. The weekly MACD is mildly bullish, but this is offset by the bearish signals from Bollinger Bands and the monthly KST. The Dow Theory shows a mixed signal with weekly mildly bullish but monthly mildly bearish. In terms of performance, Tivic Health has underperformed the S&P 500 across multiple periods, with a year-to-date return of -46.9% compared to the S&P 500's 12.22%, and a one-year return of -33.16% versus 17.14%....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-20.64%
EBIT Growth (5y)
-27.16%
EBIT to Interest (avg)
-6.19
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.22
Sales to Capital Employed (avg)
0.30
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
7.75%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.10
EV to EBIT
-0.47
EV to EBITDA
-0.50
EV to Capital Employed
1.13
EV to Sales
2.68
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-240.22%
ROE (Latest)
-186.96%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 2 Schemes (1.32%)

Foreign Institutions

Held by 1 Foreign Institutions (0.0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 0.00% vs -50.00% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -26.67% vs 0.00% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.10",
          "val2": "0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.90",
          "val2": "-1.50",
          "chgp": "-26.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.90",
          "val2": "-1.50",
          "chgp": "-26.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-22,488.40%",
          "val2": "-21,514.30%",
          "chgp": "-97.41%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -33.33% vs -33.33% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 30.49% vs 18.81% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.80",
          "val2": "1.20",
          "chgp": "-33.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-5.20",
          "val2": "-8.10",
          "chgp": "35.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-5.70",
          "val2": "-8.20",
          "chgp": "30.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-7,180.80%",
          "val2": "-7,011.10%",
          "chgp": "-16.97%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
0.10
0.10
Operating Profit (PBDIT) excl Other Income
-1.90
-1.50
-26.67%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-1.90
-1.50
-26.67%
Operating Profit Margin (Excl OI)
-22,488.40%
-21,514.30%
-97.41%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 0.00% vs -50.00% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -26.67% vs 0.00% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.80
1.20
-33.33%
Operating Profit (PBDIT) excl Other Income
-5.20
-8.10
35.80%
Interest
0.00
0.00
Exceptional Items
-0.10
0.00
Consolidate Net Profit
-5.70
-8.20
30.49%
Operating Profit Margin (Excl OI)
-7,180.80%
-7,011.10%
-16.97%
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in year ended Dec 2024 is -33.33% vs -33.33% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 30.49% vs 18.81% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Tivic Health Systems, Inc. stock-summary
stock-summary
Tivic Health Systems, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."